Results for tag: "Saracatinib"

Saracatinib is an oncology drug used to treat certain types of cancer. It is a tyrosine kinase inhibitor, meaning it works by blocking the activity of certain enzymes that are involved in the growth and spread of cancer cells. Saracatinib is used to treat non-small cell lung cancer, metastatic breast cancer, and metastatic colorectal cancer. It is also being studied for its potential to treat other types of cancer. Saracatinib is available in tablet form and is taken orally. Common side effects include nausea, vomiting, diarrhea, fatigue, and decreased appetite. More serious side effects may include liver damage, heart problems, and an increased risk of infection. The saracatinib market is a rapidly growing segment of the oncology drug market. It is expected to continue to grow as more research is conducted and new uses for the drug are discovered. Companies in the saracatinib market include AstraZeneca, Pfizer, Merck, and Novartis. Show Less Read more